Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin Baigent

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
Nephron. Clinical Practice|September 25, 2007
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) studyDaniel Zehnder, Martin J Landray, David C Wheeler, et al.
Lancet (London, England)|May 8, 2023
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patientsNatalie Staplin, Alejandro de la Sierra, Luis M Ruilope, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 27, 2020
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomesSuleman Aktaa, Gorav Batra, Lars Wallentin, et al.
Kidney International Reports|June 2, 2018
Impact of CKD on Household IncomeRachael L Morton, Iryna Schlackow, Alastair Gray, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) studyMartin J Landray, David C Wheeler, Gregory Y H Lip, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 7, 2016
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysisKevin Quach, Lyubov Lvtvyn, Colin Baigent, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation modelRunguo Wu, Claire Williams, Junwen Zhou, et al.
Plos One|January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy, Jonathan R Emberson, Patricia M Kearney, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|August 7, 2017
A policy model of cardiovascular disease in moderate-to-advanced chronic kidney diseaseIryna Schlackow, Seamus Kent, William Herrington, et al.
Nephron. Clinical Practice|September 25, 2007
Cross-sectional analysis of abnormalities of mineral homeostasis, vitamin D and parathyroid hormone in a cohort of pre-dialysis patients. The chronic renal impairment in Birmingham (CRIB) studyDaniel Zehnder, Martin J Landray, David C Wheeler, et al.
Lancet (London, England)|May 8, 2023
Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patientsNatalie Staplin, Alejandro de la Sierra, Luis M Ruilope, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 27, 2020
European Society of Cardiology methodology for the development of quality indicators for the quantification of cardiovascular care and outcomesSuleman Aktaa, Gorav Batra, Lars Wallentin, et al.
Kidney International Reports|June 2, 2018
Impact of CKD on Household IncomeRachael L Morton, Iryna Schlackow, Alastair Gray, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) studyMartin J Landray, David C Wheeler, Gregory Y H Lip, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 7, 2016
The Safety and Efficacy of Mineralocorticoid Receptor Antagonists in Patients Who Require Dialysis: A Systematic Review and Meta-analysisKevin Quach, Lyubov Lvtvyn, Colin Baigent, et al.
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation modelRunguo Wu, Claire Williams, Junwen Zhou, et al.
Plos One|January 26, 2012
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy, Jonathan R Emberson, Patricia M Kearney, et al.
Pageof 18